Top compounds associated with response to CDKL3


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0051 0.9
mRNA BRD-K66453893 CTRPv2 pan-cancer AAC 0.0042 0.9
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC -0.0051 0.9
mRNA Mdivi-1 CTRPv2 pan-cancer AAC 0.0048 0.9
mRNA C6-ceramide CTRPv2 pan-cancer AAC 0.0048 0.9
mRNA pifithrin-alpha CTRPv2 pan-cancer AAC 0.0043 0.9
mRNA quizartinib CTRPv2 pan-cancer AAC -0.0042 0.9
mRNA Crizotinib gCSI pan-cancer AAC -0.0062 0.9
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0038 0.9
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC -0.0081 0.9
Download CSV